Glimblist-PM 1 Tablet ER

Overview Glimblist-PM 1 Tablet ER

DiaBeta-XR 1 Tablet Extended Release is a dual-action medication designed to manage blood glucose. This medication complements diet and exercise to enhance glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin efficiency, resulting in reduced blood sugar. DiaBeta-XR 1 Tablet Extended Release should be administered precisely as prescribed by your physician, adhering to the specified dosage and duration. Ingestion with food is recommended to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Commonly reported adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must also seek medical consultation before use. Your doctor will assess your renal function before initiating therapy. Limit alcohol consumption as it may heighten the risk of side effects.

Uses of Glimblist-PM 1 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimblist-PM 1 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; do not fracture, crush, or chew it. It's recommended to take one Glimblist-PM extended-release tablet with a meal.

Common Side effects of Glimblist-PM 1 Tablet ER:

• Hypoglycemia (low blood glucose level)
• Headache
• Nausea
• Diarrhea
• Dizziness
• Vomiting
• Anemia (low number of red blood cells)
• Weakness
• Sinus infection

How to use Glimblist-PM 1 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Glimblist-PM 1 Extended-Release Tablet should be taken with a meal.

How Glimblist-PM 1 Tablet ER works:

Glimblist-PM 1 Tablet ER combines three distinct antidiabetic agents—glimepiride, metformin, and pioglitazone—to enhance blood sugar management when single or dual-agent regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through a multipronged approach: decreasing hepatic glucose production, retarding intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.

What if you forget to take Glimblist-PM 1 Tablet ER :

Should you forget to take a Glimblist-PM 1 Tablet ER, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.